Premium
In vitro screening of Fe 2+ ‐chelating effect by a Fenton's reaction–luminol chemiluminescence system
Author(s) -
Wada Mitsuhiro,
Komatsu Hiroaki,
Ikeda Rie,
Aburjai Talal A.,
Alkhalil Suleiman M.,
Kuroda Naotaka,
Nakashima Kenichiro
Publication year - 2014
Publication title -
luminescence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 45
eISSN - 1522-7243
pISSN - 1522-7235
DOI - 10.1002/bio.2628
Subject(s) - ethylenediaminetetraacetic acid , chemiluminescence , luminol , chemistry , chelation , phenanthroline , deferoxamine , nuclear chemistry , luminescence , fenton reaction , chromatography , inorganic chemistry , hydrogen peroxide , organic chemistry , materials science , optoelectronics
In vitro screening of a Fe 2+ ‐chelating effect using a Fenton's reaction–luminol chemiluminescence (CL) system is described. The luminescence between the reactive oxygen species generated by the Fenton's reaction and luminol was decreased on capturing Fe 2+ using a chelator. The proposed method can prevent the consumption of expensive seed compounds (drug discovery candidates) owing to the high sensitivity of CL detection. Therefore, the assay could be performed using small volumes of sample solution (150 μL) at micromolar concentrations. After optimization of the screening conditions, the efficacies of conventional chelators such as ethylenediaminetetraacetic acid (EDTA), diethylentriaminepentaacetic acid (DETAPAC), deferoxamine, deferiprone and 1,10‐phenanthroline were examined. EC 50 values for these compounds (except 1,10‐phenanthroline) were in the range 3.20 ± 0.87 to 9.57 ± 0.64 μM ( n = 3). Rapid measurement of the Fe 2+ ‐chelating effect with an assay run time of a few minutes could be achieved using the proposed method. In addition, the specificity of the method was discussed. Copyright © 2014 John Wiley & Sons, Ltd.